Accelerating Drug Discovery with Advanced Computational Modeling and Cloud Computing

DATE

November 5, 2020

TIME

11:00 a.m. PST / 2:00 p.m. EST / 18:00 GMT / 19:00 CET - Duration: 60 Minutes

Overview

Small molecule drug discovery requires identification of ligands manifesting highly potent and selective binding, while maintaining a wide variety of other ligand properties required for safety and biological efficacy. In this presentation we'll describe how integrated deployment of Schrödinger's leading computational modeling technologies and GoogleCloud's high-performance computing resources can be used to drive drug discovery projects and significantly speed up design cycles. In addition to case studies and examples from active drug discovery projects, we'll also take a look at how improvements in high-performance computing continue to open new possibilities for large scale computationally driven molecular design.

Brought to you by:

Speakers

Robert Abel
Executive Vice President of Science,
Schrödinger

Patrick Lorton
Senior Vice President and Chief Technology Officer,
Schrödinger

Jeff Huber
Contributing Editor,
C&EN Media Group

Registration

Forwarded this event? Clear the form

Email Address*

Salutation*

First Name*

Last Name*

Company*

Job Title*

Department*

Address 1*

City*

State

Zip / Post Code*

Country*

Business Phone*

Do you currently use computational chemistry software?

If so, what tools do you use:

I would like to receive more information on products and services from the American Chemical Society

*By submitting this form, you agree to receive more information on related products and services from the American Chemical Society (ACS Publications) via email, in accordance with the ACS Privacy Policy.

View On Demand Webinars